Skip to main content
Fig. 2 | BMC Complementary and Alternative Medicine

Fig. 2

From: MOK, a pharmacopuncture medicine, regulates thyroid dysfunction in L-thyroxin-induced hyperthyroidism in rats through the regulation of oxidation and the TRPV1 ion channel

Fig. 2

Effects of MOK pharmacopuncture on the changes of physiological parameters in LT4-induced hyperthyroidism rats. MOK pharmacopuncture was subcutaneously administered once daily for 2 weeks, and measured the body weight (a), and food and (b) and water (b) intake once a week. Data are presented as mean±SD (n=5 per each group). *P<0.05, **P<0.01 and ***P<0.001 vs normal (a) or control (b). Normal, normal group; Control, LT4-induced hyperthyroidism group; MOK 0.3, MOK 0.3 mg/kg-treated group in control; MOK 3, MOK 3 mg/kg-treated group in control; and PTU, PTU 10 mg/kg-treated group as a reference drug

Back to article page